Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Henry Schein 3.458.
Vertex Pharmaceuticals vs Henry Schein Net Worth and Market Cap
Vertex Pharmaceuticals (VRTX) and Henry Schein (HSIC) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $3.5B for Henry Schein. Henry Schein leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 31.8% for Henry Schein. Vertex Pharmaceuticals's net margin is 33.0% versus 2.7% for Henry Schein.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Henry Schein.| Metric | Vertex Pharmaceuticals | Henry Schein |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $3.46B |
| Cost of Revenue | $489.00M | $2.36B |
| Gross Profit | $2.85B | $1.10B |
| Operating Income | $1.25B | $200.00M |
| Net Income | $1.10B | $94.00M |
| R&D Expense | $994.00M | $0 |
| Earnings Per Share | $4.31 | $0.82 |
| Gross Margin | 85.3% | 31.8% |
| Operating Margin | 37.4% | 5.8% |
| Net Profit Margin | 33.0% | 2.7% |
| Free Cash Flow | $1.01B | $196.00M |
| Cumulative Free Cash Flow | $17.24B | $9.89B |
| Operating Cash Flow | $1.13B | $242.00M |
| Cash & Equivalents | $6.14B | $157.00M |